Insider Transactions Report for Atea Pharmaceuticals, Inc.
2026-06-23SEC Filing 4 (0001193125-26-279721)
Barbara Gayle Duncan, a director at Atea Pharmaceuticals, Inc., reported several transactions on June 18, 2026. She acquired 29,600 shares of Common Stock under transaction code "M" (